INTRODUCTION: Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia. In the present case, an evidence-guided treatment plan of supplements and lifestyle changes were used to support the patient. CASE PRESENTATION: A 56-y-old female presented to her primary care physician for a routine physical in 2001. Complete blood cell results suggest pathology among white blood cells. Flow cytometry was used to confirm the presence of CLL. Other than an episode of splenomegaly in 2005 and mild lymphadenopathy, the patient has remained asymptomatic since diagnosis in 2001. In late 2001, the patient began a physician-assisted regimen of alternative dietary supplements and lifestyle changes. CONCLUSION: Nutritional supplementation along with lifestyle changes appears to have supported the maintenance of stable and indolent CLL in this patient. It is important for physicians to be prepared to engage with their patients on use of supplements and lifestyle changes in managing their disease.
INTRODUCTION: Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia. In the present case, an evidence-guided treatment plan of supplements and lifestyle changes were used to support the patient. CASE PRESENTATION: A 56-y-old female presented to her primary care physician for a routine physical in 2001. Complete blood cell results suggest pathology among white blood cells. Flow cytometry was used to confirm the presence of CLL. Other than an episode of splenomegaly in 2005 and mild lymphadenopathy, the patient has remained asymptomatic since diagnosis in 2001. In late 2001, the patient began a physician-assisted regimen of alternative dietary supplements and lifestyle changes. CONCLUSION: Nutritional supplementation along with lifestyle changes appears to have supported the maintenance of stable and indolent CLL in this patient. It is important for physicians to be prepared to engage with their patients on use of supplements and lifestyle changes in managing their disease.
Authors: R Schroers; F Griesinger; L Trümper; D Haase; B Kulle; L Klein-Hitpass; L Sellmann; U Dührsen; J Dürig Journal: Leukemia Date: 2005-05 Impact factor: 11.528
Authors: Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps Journal: Blood Date: 2008-01-23 Impact factor: 22.113